3'-deoxy-3'-[18F]fluorothymidine
Sponsors
UNICANCER, Mayo Clinic, Barbara Ann Karmanos Cancer Institute, Abramson Cancer Center at Penn Medicine, Virginia Commonwealth University
Conditions
Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)Brain and Central Nervous System TumorsBreast CancerChronic Myeloproliferative DisordersHead and Neck CancerLeukemiaLymphomaLymphoproliferative Disorder
Early Phase 1
Phase 1
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
TerminatedNCT01283178
Start: 2011-07-31End: 2016-09-30Updated: 2016-10-31
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
CompletedNCT01480050
Start: 2012-05-31End: 2017-06-01Updated: 2019-05-22
Unknown Phase
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
CompletedNCT00534274
Start: 2006-11-30End: 2013-09-30Updated: 2014-12-16
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RecruitingNCT00935090
Start: 2009-09-30End: 2028-05-31Updated: 2025-07-08
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer
WithdrawnNCT01018251
Start: 2009-03-31End: 2011-06-30Updated: 2015-12-15